Victoria Baltrus - Mar 1, 2024 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
Chief Accounting Officer
Signature
/s/ Melissa Curtin, Attorney-in-fact
Stock symbol
OSCR
Transactions as of
Mar 1, 2024
Transactions value $
-$535,267
Form type
4
Date filed
3/5/2024, 04:22 PM
Previous filing
Dec 5, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +4.12K +6.9% 63.9K Mar 1, 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +4.81K +7.53% 68.7K Mar 1, 2024 Direct F1
transaction OSCR Class A Common Stock Options Exercise +7.5K +10.92% 76.2K Mar 1, 2024 Direct F1
transaction OSCR Class A Common Stock Award +75.6K +99.3% 152K Mar 1, 2024 Direct F1, F2
transaction OSCR Class A Common Stock Sale -$535K -33.7K -22.2% $15.88 118K Mar 4, 2024 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -4.12K -20% $0.00 16.5K Mar 1, 2024 Class A Common Stock 4.12K Direct F1, F5
transaction OSCR Restricted Stock Units Options Exercise $0 -4.81K -14.29% $0.00 28.9K Mar 1, 2024 Class A Common Stock 4.81K Direct F1, F6
transaction OSCR Restricted Stock Units Options Exercise $0 -7.5K -11.11% $0.00 60K Mar 1, 2024 Class A Common Stock 7.5K Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The Issuer previously granted the Reporting Person an award of 75,643 restricted stock units that vested on March 1, 2024, following the Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved.
F3 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.76 to $16.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F5 The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2022.
F6 The restricted stock units vested with respect to 25% of the shares on September 1, 2022, and will vest with respect to the remaining shares in 12 equal quarterly installments thereafter.
F7 The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2023.